[{"address1": "30 Technology Drive", "city": "Warren", "state": "NJ", "zip": "07059", "country": "United States", "phone": "908 941 1900", "website": "https://www.aquestive.com", "industry": "Drug Manufacturers - Specialty & Generic", "industryKey": "drug-manufacturers-specialty-generic", "industryDisp": "Drug Manufacturers - Specialty & Generic", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Aquestive Therapeutics, Inc. operates as a pharmaceutical company in the United States and internationally. It offers Libervant, a buccal soluble film formulation of diazepam for the treatment of seizures; Suboxone, a sublingual film formulation of buprenorphine and naloxone for the treatment of opioid dependence; Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; KYNMOBI a sublingual film formulation of apomorphine for the treatment of episodic off-periods in Parkinson's disease; and Azstarys, a once-daily product for the treatment of attention deficit hyperactivity disorder. The company's proprietary pipeline products include Anaphylm, an epinephrine sublingual film, which is in phase 3 clinical trial for the emergency treatment of allergic reactions, including anaphylaxis; and AQST-108, a topical gel that is in phase 2 clinical trial for the treatment of alopecia areata. In addition, it develops PharmFilm technology for patients suffering from certain central nervous system disorders; and Adrenaverse, an epinephrine prodrug platform. The company was incorporated in 2004 and is headquartered in Warren, New Jersey.", "fullTimeEmployees": 142, "companyOfficers": [{"maxAge": 1, "name": "Mr. Daniel  Barber", "age": 49, "title": "CEO, President & Director", "yearBorn": 1976, "fiscalYear": 2024, "totalPay": 1097468, "exercisedValue": 0, "unexercisedValue": 469825}, {"maxAge": 1, "name": "Ms. Lori J. Braender BSBA, Esq., J.D.", "age": 69, "title": "Chief Legal Officer, Chief Compliance Officer & Secretary", "yearBorn": 1956, "fiscalYear": 2024, "totalPay": 737771, "exercisedValue": 0, "unexercisedValue": 255600}, {"maxAge": 1, "name": "Mr. A. Ernest Toth Jr.", "age": 66, "title": "Chief Financial Officer", "yearBorn": 1959, "fiscalYear": 2024, "totalPay": 667187, "exercisedValue": 0, "unexercisedValue": 11400}, {"maxAge": 1, "name": "Ms. Cassie  Jung", "age": 45, "title": "Chief Operating Officer", "yearBorn": 1980, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Peter E. Boyd", "age": 60, "title": "Senior Vice President of Information Technology & Chief People Officer", "yearBorn": 1965, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Gary H. Slatko M.D., MBA", "age": 68, "title": "Interim Chief Medical Officer", "yearBorn": 1957, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Sherry  Korczynski", "age": 55, "title": "Chief Commercial Officer", "yearBorn": 1970, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Melina T. Cioffi Pharm.D.", "age": 42, "title": "Senior Vice President of Regulatory Affairs", "yearBorn": 1983, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Matthew William Davis M.D., R.Ph.", "title": "Chief Development Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Robert Charles Arnold", "title": "VP of Finance, Controller & Assistant Secretary", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 9, "boardRisk": 6, "compensationRisk": 10, "shareHolderRightsRisk": 8, "overallRisk": 9, "governanceEpochDate": 1769904000, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 3.75, "open": 3.75, "dayLow": 3.61, "dayHigh": 3.8, "regularMarketPreviousClose": 3.75, "regularMarketOpen": 3.75, "regularMarketDayLow": 3.61, "regularMarketDayHigh": 3.8, "payoutRatio": 0.0, "beta": 1.664, "forwardPE": -6.9303365, "volume": 2570809, "regularMarketVolume": 2570809, "averageVolume": 4949505, "averageVolume10days": 9525830, "averageDailyVolume10Day": 9525830, "bid": 2.71, "ask": 4.67, "bidSize": 2, "askSize": 2, "marketCap": 445311360, "fiftyTwoWeekLow": 2.12, "fiftyTwoWeekHigh": 7.55, "allTimeHigh": 20.696, "allTimeLow": 0.618, "priceToSalesTrailing12Months": 10.26134, "fiftyDayAverage": 4.9146, "twoHundredDayAverage": 4.599525, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 357624352, "profitMargins": -1.58949, "floatShares": 111904915, "sharesOutstanding": 122003113, "sharesShort": 20386052, "sharesShortPriorMonth": 24139081, "sharesShortPreviousMonthDate": 1767139200, "dateShortInterest": 1769731200, "sharesPercentSharesOut": 0.1671, "heldPercentInsiders": 0.03258, "heldPercentInstitutions": 0.61667, "shortRatio": 3.28, "shortPercentOfFloat": 0.1916, "impliedSharesOutstanding": 122003113, "bookValue": -0.034, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -68979000, "trailingEps": -0.7, "forwardEps": -0.52667, "enterpriseToRevenue": 8.241, "enterpriseToEbitda": -6.478, "52WeekChange": 0.19047618, "SandP52WeekChange": 0.11471915, "quoteType": "EQUITY", "currentPrice": 3.65, "targetHighPrice": 12.0, "targetLowPrice": 6.0, "targetMeanPrice": 9.22222, "targetMedianPrice": 9.0, "recommendationMean": 1.22222, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 9, "totalCash": 129063000, "totalCashPerShare": 1.058, "ebitda": -55203000, "totalDebt": 41376000, "quickRatio": 5.508, "currentRatio": 5.931, "totalRevenue": 43397000, "revenuePerShare": 0.437, "returnOnAssets": -0.25496998, "grossProfits": 26158000, "freeCashflow": -25766250, "operatingCashflow": -50452000, "revenueGrowth": -0.054, "grossMargins": 0.60276, "ebitdaMargins": -1.27205, "operatingMargins": -0.89631, "financialCurrency": "USD", "symbol": "AQST", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "corporateActions": [], "postMarketTime": 1771029978, "regularMarketTime": 1771016402, "exchange": "NGM", "messageBoardId": "finmb_8142504", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -2.66666, "regularMarketPrice": 3.65, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1532525400000, "postMarketChangePercent": -0.27397233, "postMarketPrice": 3.64, "postMarketChange": -0.00999999, "regularMarketChange": -0.0999999, "regularMarketDayRange": "3.61 - 3.8", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 4949505, "fiftyTwoWeekLowChange": 1.5300002, "fiftyTwoWeekLowChangePercent": 0.7216982, "fiftyTwoWeekRange": "2.12 - 7.55", "fiftyTwoWeekHighChange": -3.9, "fiftyTwoWeekHighChangePercent": -0.51655626, "fiftyTwoWeekChangePercent": 19.047619, "earningsTimestampStart": 1762376400, "earningsTimestampEnd": 1762376400, "earningsCallTimestampStart": 1762434000, "earningsCallTimestampEnd": 1762434000, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -0.7, "epsForward": -0.52667, "epsCurrentYear": -0.59, "shortName": "Aquestive Therapeutics, Inc.", "longName": "Aquestive Therapeutics, Inc.", "marketState": "CLOSED", "priceEpsCurrentYear": -6.186441, "fiftyDayAverageChange": -1.2645998, "fiftyDayAverageChangePercent": -0.2573149, "twoHundredDayAverageChange": -0.9495249, "twoHundredDayAverageChangePercent": -0.20643976, "priceToBook": -107.352936, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.2 - Strong Buy", "cryptoTradeable": false, "displayName": "Aquestive Therapeutics", "trailingPegRatio": null, "__fetch_time": "2026-02-14"}]